Onradivir significantly shortens recovery time in adults with uncomplicated influenza A. Read more. Learn more.

On June 10th, the Guangzhou Laboratoryheld a press conference for Onradivir, unveiling the development process and advantages ...

China's top drug regulator has approved a homegrown flu treatment that acts on a novel protein target, adding to the arsenal ...

Hospitalized flu patients given the antiviral drug oseltamivir (Tamiflu) are less likely to die in the hospital, be released ...

A LARGE international trial has found that a single dose of the RSVPreF3 OA vaccine offers strong and sustained protection against respiratory syncytial virus (RSV)-related lower respiratory tract ...

Editor's Note: This is an expanded version of a story published earlier today (Nov 1, 2005). Nov 1, 2005 (CIDRAP News) – President George W. Bush today proposed $7.1 billion in spending to prepare for ...

Researchers examined the safety and efficacy of 3 different onradivir dosing regimens vs placebo in patients with acute uncomplicated influenza A virus infection.

Researchers aimed to describe the various serious infections and their risk factors associated with Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome.

The efficacy of onradivir in ameliorating influenza symptoms was higher than that of placebo in patients with acute uncomplicated influenza A infection. Patients who receive onradivir for ...

Researchers explored outcomes between patient with pneumonia who were diagnosed with vs without confirmatory imaging in the urgent care clinic setting.